Inactive Instrument

SEMR PARA Stock

LGST

KYG8028L1077

Semper Paratus Acquisition Corporation (Semper Paratus) is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It intends to concentrate its efforts to pursue an acquisition opportunity in the transportation, supply chain and logistics industry. The Company has not commenced any operations nor generated any revenues.

Employees

Sector

More about the company

24-04-29	Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-02-13	Semper Paratus Acquisition Corporation(NasdaqGM:LGST) dropped from NASDAQ Composite Index	CI
24-02-13	Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in a reverse merger transaction.	CI
24-02-01	Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal	MT
23-11-13	Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-21	Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-06-29	Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public	MT
23-06-29	Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing	RE
23-06-29	Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal	RE
23-06-28	Tevogen Bio Inc entered into a merger agreement to acquire Semper Paratus Acquisition Corporation for $1.5 billion in a reverse merger transaction.	CI
23-06-08	Insider Sell: Semper Paratus Acquisition	MT
23-06-07	Semper Paratus Acquisition Corporation Announces CEO Changes	CI
23-06-07	Semper Paratus Acquisition Corporation Announces CFO Changes	CI

24-04-26	SEMR PARA : Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments - Form 8-K	PU
24-02-14	Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN	AQ
24-02-01	Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio	AQ
24-01-24	Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq	AQ
24-01-05	Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination	AQ

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/7/23	Semper Paratus Sponsor LLC	Other	Company	7,988,889	66.6667%
6/7/23	Semper Paratus Sponsor LLC	Free	Company	7,988,889	66.6667%
1/30/23	Semper Paratus Sponsor LLC	Conversion	Company	11,983,333	100.0000%

SEMR PARA Stock

Stocks

LGST

KYG8028L1077

Latest news : SEMR PARA

Press Releases: SEMR PARA

Latest insider transactions

Company Profile